Federal Register / Vol. 62, No. 23 / Tuesday, February 4, 1997 / Notices 5239

Grants Management Branch, Bureau of

Health Professions, Health Resources

and Services Administration, Parklawn

Building, Room 8C–26, 5600 Fishers

Lane, Rockville, Maryland 20857.

For applicants who are unable to

access application materials

electronically, a hard copy will be

provided be contacting the HRSA Grants

Application Center. The Center may be

contacted by: Telephone Number: 1–

888–300–HRSA; FAX Number: 301–

309–0579; Email Address:

HRSA.GAC@IX.NETCOM.COM.

Completed applications should be

returned to: Grants Management Officer

(CFDA#), HRSA Grants Application

Center, 40 West Gude Drive, Suite 100,

Rockville, Maryland 20850.

Paperwork Reduction Act

The standard application form PHS

6025–1, HRSA Competing Training

Grant Application, General Instructions

and supplement for these grant

programs have been approved by the

Office of Management and Budget under

the Paperwork Reduction Act. The OMB

Clearance Number is 0915–0060.

Deadline Date

The deadline dates for receipt of

applications for each of these programs

are shown in Table 1. Applications will

be considered to be ‘‘on time’’ if they are

either:

(1) Received on or before the

established deadline date, or

(2) Sent on or before the established

deadline date and received in time for

orderly processing. (Applicants should

request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or U.S. Postal Service. Private metered

postmarks shall not be acceptable as

proof of timely mailing.)

Late applications not accepted for

processing will be returned to the

applicant. In addition, applications

which exceed the page limitation and/

or do not follow format instructions will

not be accepted for processing and will

be returned to the applicant.

TABLE 1

PHS Section No., Title, CFDA No., Regulation Type of assistance

Period of

support

(years)

Deadline

date

746(a)(1), Basic/Core AHEC, 93.824, 42 CFR part 57 subpart MM .............. Cooperative Agreement ..................... 3 3/21/97

746(a)(3), State Supported Model AHEC, 93.107 .......................................... Cooperative Agreement ..................... 3 3/21/97

These programs are not subject to the

provisions of Executive Order 12372,

Intergovernmental Review of Federal

Programs (as implemented through 45

CFR part 100) or the Public Health

System Reporting Requirements.

Dated: January 28, 1997.

Ciro V. Sumaya,

Administrator.

[FR Doc. 97–2682 Filed 2–3–97; 8:45 am]

BILLING CODE 4160–15–P

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

following National Heart, Lung, and

Blood Institute Special Emphasis Panel.

The meeting will be open to the

public to provide concept review of

proposed contract or grant solicitations.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

inform the Contact Person listed below

in advance of the meeting.

Name of Panel: Heart and Vascular

Diseases Research Opportunities.

Dates of Meeting: March 26, 1997.

Time of Meeting: 8:30 a.m.

Place of Meeting: NIH, Building 31, C

Wing, Conference Room 6, 31 Center Drive,

Bethesda Maryland 20892.

Agenda: Discussion of Future Initiatives

with Emphasis on Critical Health Care Needs

and Research Opportunities Related to Heart

and Vascular Diseases.

Contact Person: Frank Altieri, Ph.D.,

NHLBI/DHVD, Two Rockledge Center, 6701

Rockledge Drive, Rm. 9166, MSC 7940,

Bethesda, Maryland 20892, (301) 435–0494.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health.)

Dated: January 29, 1997.

Paula N. Hayes,

Acting Committee management Officer, NIH.

[FR Doc. 97–2725 Filed 2–3–97; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meetings:

Name of SEP: Conjugated Pneumococcal

Vaccine in Sickle Cell Disease.

Date: February 25, 1997.

Time: 8:00 a.m.

Place: Hyatt Regency Hotel, One Metro

Center, Bethesda, Maryland 20814.

Contact Person: Ivan Baines, Ph.D., Two

Rockledge Center, Room 7184, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

grant applications.

This notice is being published less than

fifteen days prior to this meeting due to the

urgent need to meet timing limitations

imposed by the grant review and funding

cycle.

Name of SEP: Collaborative Study on the

Genetics of Asthma.

Date: March 18, 1997.

Time: 8:00 a.m.

Place: Crystal City Marriott, 1999 Jefferson

Davis Highway, Arlington, Virginia 22202.

Contact Person: C. James Scheirer, Ph.D,

Two Rockledge Center, Room 7220, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0266.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

Sections 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health.)

Dated: January 29, 1997.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–2727 Filed 2–3–97; 8:45 am]

BILLING CODE 4140–01–M